ArticleResearch in social & administrative pharmacy : RSAP2020
Patterns and predictors of older adult Medicare Part D beneficiaries' receipt of medication therapy management.
Article in Research in social & administrative pharmacy : RSAP, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.
- Impact of medication therapy management programs on potentially inappropriate medication use in older adults: A systematic review.Journal of managed care & specialty pharmacy · 2024Pooled it
- Characterizing Medicare Medication Therapy Management program enrollees with central nervous system-active polypharmacy.Journal of managed care & specialty pharmacy · 2026Observational
- Receipt of Medicare Part D comprehensive medication reviews in older adults with dementia.Journal of managed care & specialty pharmacy · 2025Article
- Impact of comprehensive medication reviews on potentially inappropriate medication discontinuation in Medicare beneficiaries.Journal of the American Geriatrics Society · 2024Article
- Racial and ethnic disparities related to the Medicare Part D Medication Therapy Management Program.Journal of managed care & specialty pharmacy · 2024Article
- Comprehensive Medication Review Completion Rates and Disparities After Medicare Star Rating Measure.JAMA health forum · 2024Observational
- Applying the Andersen behavioral model to the medication therapy management program: an approach for improving medication safety in older adults.Frontiers in public health · 2024Article
- Racial and ethnic disparities in the enrolment of medicare medication therapy management programs.Journal of pharmaceutical health services research : an official journal of the Royal Pharmaceutical Society of Great Britain · 2023Article
- Racial and ethnic disparities in Medicare Part D medication therapy management services utilization.Exploratory research in clinical and social pharmacy · 2023Article
- Predictors of Receipt of Comprehensive Medication Reviews in Older Adults.The journals of gerontology. Series A, Biological sciences and medical sciences · 2023Article
- Racial/ethnic disparities in the enrollment of Medication Therapy Management programs among Medicare beneficiaries with Alzheimer's disease and related dementias.Current medical research and opinion · 2022Article
- Effects of the Medicare Part D Comprehensive Medication Review on Racial and Ethnic Disparities in Medication Adherence.American health & drug benefits · 2021Article
- Exploring Racial and Ethnic Disparities in Medication Adherence Among Medicare Comprehensive Medication Review Recipients.Exploratory research in clinical and social pharmacy · 2021Article
- Positive deviants for medication therapy management: A mixed-methods comparative case study of community pharmacy practices.Research in social & administrative pharmacy : RSAP · 2021Article
- Understanding the Socioeconomic and Geographical Characteristics of Beneficiaries Receiving a Comprehensive Medication Review.Journal of managed care & specialty pharmacy · 2020Article
- Primary healthcare policy and vision for community pharmacy and pharmacists in the United States.Pharmacy practiceArticle
- Bridging the knowledge gap: Med Wise Rx helps older adults navigate comprehensive medication reviews.Journal of the American Pharmacists Association : JAPhAArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 3 institutions in 1 country.
Funding
Abstract
backgroundMedicare Part D medication therapy management (MTM) includes an annual comprehensive medication review (CMR) as a strategy to mitigate suboptimal medication use in older adults.
objectivesTo describe the characteristics of Medicare beneficiaries who were eligible, offered, and received a CMR in 2013 and 2014 and identify potential disparities.
methodsThis nationally representative cross-sectional study used a 20% random sample of Medicare Part A, B, and D data linked with Part D MTM files. A total of 5,487,343 and 5,822,188 continuously enrolled beneficiaries were included in 2013 and 2014, respectively. CMR use was examined among a subset of 620,164 and 669,254 of these beneficiaries enrolled in the MTM program in 2013 and 2014. Main measures were MTM eligibility, CMR offer, and CMR receipt. The Andersen Behavioral Model of Health Services Use informed covariates selected.
resultsIn 2013 and 2014, 505,658 (82%) and 649,201 (97%) MTM eligible beneficiaries were offered a CMR, respectively. Among those, CMR receipt increased from 81,089 (16%) in 2013 to 119,181 (18%) in 2014. The mean age of CMR recipients was 75 years (±7) and the majority were women, White, and without low-income status. In 2014, lower odds of CMR receipt were associated with increasing age (adjusted odds ratio (OR) = 0.99 (95% confidence interval (CI) = 0.994-0.995), male sex (OR = 0.93, 95% CI = 0.926-0.951), being any non-White race/ethnicity except Black, dual-Medicaid status (OR = 0.64, 95% CI = 0.626-0.650), having a hospitalization (OR = 0.87, 95% CI = 0.839-0.893) or emergency department visit (OR = 0.67, 95% CI = 0.658-0.686), and number of comorbidities (OR = 0.90, 95% CI = 0.896-0.905).
conclusionsCMR offers and completion rates have increased, but disparities in CMR receipt by age, sex, race, and dual-Medicaid status were evident. Changes to MTM targeting criteria and CMR offer strategies may be warranted to address disparities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.